{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:20:52Z","timestamp":1793071252434,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.anndiagpath.2021.151792","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T05:15:31Z","timestamp":1626326131000},"page":"151792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Tumor Budding is a reliable predictor for death and metastasis in invasive ductal breast cancer and correlates with other prognostic clinicopathological parameters"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7481-4718","authenticated-orcid":false,"given":"O\u011fuzhan","family":"Okcu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2587-214X","authenticated-orcid":false,"given":"\u00c7i\u011fdem","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayram","family":"\u015een","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8321-4829","authenticated-orcid":false,"given":"Medeni","family":"Arpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8247-3781","authenticated-orcid":false,"given":"Recep","family":"Bedir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.anndiagpath.2021.151792_bb0005","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151792_bb0010","series-title":"Breast Tumours, WHO Classification of Tumours","first-page":"82","article-title":"Invasive breast carcinoma: general overview","author":"Rakha","year":"2019"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151792_bb0015","first-page":"8500","article-title":"Clinicopathological classification and traditional prognostic indicators of breast cancer","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2021.151792_bb0020","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the international tumor budding consensus conference (ITBCC) 2016","volume":"30","author":"Lugli","year":"2017","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151792_bb0025","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3748\/wjg.v16.i6.732","article-title":"ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients","volume":"16","author":"Hostettler","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151792_bb0030","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151792_bb0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/PAS.0b013e318184cd55","article-title":"Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer","volume":"33","author":"Wang","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151792_bb0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00428-019-02719-1","article-title":"Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma","volume":"476","author":"Petrova","year":"2020","journal-title":"Virchows Arch"},{"issue":"10","key":"10.1016\/j.anndiagpath.2021.151792_bb0045","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1002\/hed.25872","article-title":"Hallmarks of cancer: tumor budding as a sign of invasion and metastasis in head and neck cancer","volume":"41","author":"M\u00e4kitie","year":"2019","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151792_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cll.2018.02.006","article-title":"Breast carcinoma: updates in molecular profiling 2018","volume":"38","author":"Bandyopadhyay","year":"2018","journal-title":"Clin Lab Med"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151792_bb0060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5858\/arpa.2013-0566-CP","article-title":"Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast","volume":"138","author":"Fitzgibbons","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151792_bb0065","first-page":"853","article-title":"Quality of breast cancer surgical pathology reports","volume":"19","author":"Vallacha","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151792_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/tbj.12441","article-title":"Effect of Ki-67 on immunohistochemical classification of luminal a to luminal B subtypes of breast carcinoma","volume":"21","author":"Cirqueira","year":"2015","journal-title":"Breast J"},{"issue":"8","key":"10.1016\/j.anndiagpath.2021.151792_bb0075","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/djy088","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK): an abridged explanation and elaboration","volume":"110","author":"Sauerbrei","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151792_bb0080","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/bjc.2015.287","article-title":"The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer","volume":"113","author":"Gujam","year":"2015","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151792_bb0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10549-015-3333-3","article-title":"High tumor budding stratifies breast cancer with metastatic properties","volume":"150","author":"Salhia","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151792_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.33545\/pathol.2019.v2.i1c.25","article-title":"Evaluation of clinicopathologic significance of tumor budding in breast carcinoma","volume":"2","author":"Masilamani","year":"2019","journal-title":"Int. J. Clin. Diagn. Pathol."},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151792_bb0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.prp.2013.01.009","article-title":"The prognostic value of tumor budding in invasive breast cancer","volume":"209","author":"Liang","year":"2013","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.anndiagpath.2021.151792_bb0100","first-page":"EC25","article-title":"Tumour budding and MMP-2 expression in breast invasive ductal carcinoma","volume":"12","author":"Gabal","year":"2018","journal-title":"J. Clin. Diagnostic Res."},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151792_bb0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.18231\/j.jdpo.2019.024","article-title":"Tumor budding in invasive carcinoma of breast of no special type (NST): value as a prognostic factor","volume":"4","author":"Renuka","year":"2019","journal-title":"J. Diagn. Pathol. Oncol."},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151792_bb0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/IJPM.IJPM_120_18","article-title":"Tumor buddingin infiltrating breast carcinoma: correlation with known clinicopathological parameters and hormone receptor status","volume":"62","author":"Agarwal","year":"2019","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.anndiagpath.2021.151792_bb0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.humpath.2017.06.008","article-title":"High tumor budding count is associated with adverse clinicopathologic features and poor prognosis in breast carcinoma","volume":"66","author":"Li","year":"2017","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151792_bb0120","doi-asserted-by":"crossref","first-page":"651","DOI":"10.18632\/oncotarget.199","article-title":"Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget","volume":"1","author":"Zlobec","year":"2010","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151792_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41571-020-0422-y","article-title":"Tumour budding in solid cancers","volume":"18","author":"Lugli","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151792_bb0130","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jcp.24347","article-title":"Carcinoma-associated fibroblasts: nonneoplastic tumour-promoting mesenchymal cells","volume":"228","author":"Polanska","year":"2013","journal-title":"J Cell Physiol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2021.151792_bb0135","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1002\/hed.25872","article-title":"Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer","volume":"41","author":"M\u00e4kitie","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.anndiagpath.2021.151792_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2019.02.002","article-title":"Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma","volume":"87","author":"Meyer","year":"2019","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151792_bb0145","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1365-2559.2012.04350.x","article-title":"Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase1 in nasopharyngeal carcinoma","volume":"61","author":"Luo","year":"2012","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151792_bb0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/path.4668","article-title":"An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas","volume":"238","author":"McCart Reed","year":"2016","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151792_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/PAS.0000000000001181","article-title":"Tumor budding and prognosis in gastric adenocarcinoma","volume":"43","author":"Kemi","year":"2019","journal-title":"Am J Surg Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:33:22Z","timestamp":1761078802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913421000927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":30,"alternative-id":["S1092913421000927"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151792","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor Budding is a reliable predictor for death and metastasis in invasive ductal breast cancer and correlates with other prognostic clinicopathological parameters","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151792"}}